Subscribe
shutterstock_1562017276_theadesign
TheaDesign / Shutterstock.com
17 December 2020Generics

Lawyers warn of Irish Sea split over SPCs

The UK is facing a divergence in supplementary protection certificate (SPC) regulations across the Irish Sea post-Brexit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
MSF urges EU to rid market of ‘avoidable suffering’ from SPCs
30 November 2020   Médecins Sans Frontières has warned that the European Commission’s commitment to the supplementary protection certificate system risks undermining its promise to improve drug accessibility.
Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Europe
MSF urges EU to rid market of ‘avoidable suffering’ from SPCs
30 November 2020   Médecins Sans Frontières has warned that the European Commission’s commitment to the supplementary protection certificate system risks undermining its promise to improve drug accessibility.
Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.

More on this story

Europe
MSF urges EU to rid market of ‘avoidable suffering’ from SPCs
30 November 2020   Médecins Sans Frontières has warned that the European Commission’s commitment to the supplementary protection certificate system risks undermining its promise to improve drug accessibility.
Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility